Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol ; volume:19 ; number:1 ; day:26 ; month:1 ; year:2019 ; pages:1-7 ; date:12.2019
BMC pediatrics ; 19, Heft 1 (26.1.2019), 1-7, 12.2019
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Takagi, Masatoshi
Ogawa, Chitose
Aoki-Nogami, Yuki
Iehara, Tomoko
Ishibashi, Eri
Imai, Minoru
Kihara, Tetsuro
Nobori, Kiyoshi
Hasebe, Kazuhisa
Mizutani, Shuki
Kimura, Toshimi
Nagata, Masashi
Yasuhara, Masato
Yoshimura, Kenichi
Yorozu, Pariko
Hosoi, Hajime
Koike, Ryuji
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12887-019-1409-7
- URN
-
urn:nbn:de:101:1-2019030512315407932252
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takagi, Masatoshi
- Ogawa, Chitose
- Aoki-Nogami, Yuki
- Iehara, Tomoko
- Ishibashi, Eri
- Imai, Minoru
- Kihara, Tetsuro
- Nobori, Kiyoshi
- Hasebe, Kazuhisa
- Mizutani, Shuki
- Kimura, Toshimi
- Nagata, Masashi
- Yasuhara, Masato
- Yoshimura, Kenichi
- Yorozu, Pariko
- Hosoi, Hajime
- Koike, Ryuji
- SpringerLink (Online service)
Ähnliche Objekte (12)
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
Stem Cell Transplantation for Relapsed or Refractory Pediatric Solid Tumors
Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study
Real-World Use and Outcomes of Olaparib: a Population-Based Cohort Study
Epilepsy surgery in pediatric refractory status epilepticus
Cancer morbidity and mortality after pediatric solid organ transplantation—a nationwide register study
Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
Purification of Refractory Metals by Solid-State Refining
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
Stem Cell Transplantation for Relapsed or Refractory Pediatric Solid Tumors
Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study
Real-World Use and Outcomes of Olaparib: a Population-Based Cohort Study
Epilepsy surgery in pediatric refractory status epilepticus
Cancer morbidity and mortality after pediatric solid organ transplantation—a nationwide register study
Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours
Purification of Refractory Metals by Solid-State Refining
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
Stem Cell Transplantation for Relapsed or Refractory Pediatric Solid Tumors
Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study
Real-World Use and Outcomes of Olaparib: a Population-Based Cohort Study
Epilepsy surgery in pediatric refractory status epilepticus
Cancer morbidity and mortality after pediatric solid organ transplantation—a nationwide register study
Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours